ArticleAnnals of oncology : official journal of the European Society for Medical Oncology2021

Structural basis of acquired resistance to selpercatinib and pralsetinib mediated by non-gatekeeper RET mutations.

V Subbiah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.